ICU Medical (ICUI)
Builds infusion pumps, IV consumables, and vital-care devices for clinical workflows.
$164.08
vs last close+3.10 (+1.93%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 553 | 588 | 567 | 596 | 589 | 630 | 605 | 549 | 537 | 540 | 530 | 552 |
| Cost of revenue | 369 | 416 | 381 | 389 | 384 | 403 | 395 | 341 | 336 | 338 | 357 | 317 |
| Gross profit | 184 | 172 | 185 | 207 | 205 | 227 | 210 | 208 | 201 | 202 | 173 | 235 |
| 161 | 184 | 196 | 200 | 197 | 190 | 197 | 197 | 187 | 177 | 142 | 196 | |
| Research & development | 21 | 22 | 22 | 23 | 21 | 22 | 23 | 22 | 21 | 21 | 21 | 23 |
| Selling, general & administrative | 149 | 155 | 158 | 160 | 163 | 159 | 157 | 159 | 153 | 156 | 155 | 152 |
| Other expenses | −8 | 7 | 16 | 17 | 13 | 8 | 17 | 16 | 13 | 0 | −33 | 21 |
| Operating income | 23 | −12 | −11 | 8 | 8 | 38 | 13 | 11 | 14 | 25 | 31 | 39 |
| −28 | −24 | −26 | −27 | −26 | −29 | −24 | 26 | −18 | −44 | −35 | −16 | |
| Interest income | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 0 | 2 | 2 | 3 |
| Interest expense | 26 | 27 | 26 | 27 | 27 | 26 | 29 | 23 | 20 | 25 | 20 | 19 |
| Other non-operating income | 11 | −2 | 0 | 1 | −1 | 3 | −1 | −46 | −2 | 19 | 52 | −3 |
| Income before tax | −5 | −37 | −37 | −20 | −18 | 8 | −11 | 37 | −4 | −18 | −5 | 23 |
| Income tax expense | −13 | −20 | 3 | 2 | 15 | 32 | 5 | 1 | −1 | −3 | −35 | 7 |
| Net income from continuing operations | 7 | −17 | −39 | −21 | −33 | −24 | −15 | 35 | −3 | −16 | 30 | 16 |
| Other adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
| Net income | 7 | −17 | −39 | −21 | −33 | −24 | −15 | 35 | −3 | −16 | 30 | 19 |
| EPS, basic | $0.30 | −$0.71 | −$1.63 | −$0.88 | −$1.35 | −$0.97 | −$0.63 | $1.43 | −$0.14 | −$0.64 | $1.22 | $0.76 |
| EPS, diluted | $0.30 | −$0.71 | −$1.63 | −$0.88 | −$1.35 | −$0.97 | −$0.63 | $1.43 | −$0.14 | −$0.64 | $1.20 | $0.76 |
| Weighted average shares, basic | 24 | 24 | 24 | 24 | 24 | 24 | 25 | 25 | 25 | 25 | 25 | 25 |
| Weighted average shares, diluted | 24 | 24 | 24 | 24 | 24 | 24 | 25 | 25 | 25 | 25 | 25 | 25 |
| EBITDA | 285 | 47 | 45 | 62 | 65 | 87 | 64 | 106 | 67 | 61 | 29 | 141 |
| Depreciation & amortization | 274 | 57 | 56 | 55 | 56 | 53 | 49 | 50 | 51 | 54 | 50 | 100 |
| EBIT | 12 | −10 | −10 | 7 | 9 | 34 | 14 | 57 | 16 | 6 | −21 | 42 |
